Study of Selected X-linked Disorders: Goltz Syndrome
| Status: | Active, not recruiting |
|---|---|
| Conditions: | Dermatology |
| Therapuetic Areas: | Dermatology / Plastic Surgery |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 8/12/2018 |
| Start Date: | June 2007 |
| End Date: | January 2020 |
Pathogenesis of Focal Dermal Hypoplasia or Goltz Syndrome and Related Disorders
Focal dermal hypoplasia, or Goltz syndrome, results from genetic changes, or mutations in the
PORCN gene located on the X chromosome. This neurodevelopmental disorder is characterized by
birth defects of the skin, skeleton, eyes, and in some cases other organs. Our team is
working to obtain a better understanding of how mutations in PORCN lead to the clinical
features of Goltz syndrome. We are also trying to identify the genetic change in those
patients where no mutations in PORCN have been found. We are also investigating conditions
with phenotypes similar to Goltz syndrome to determine if they also have mutations in PORCN.
We are collecting blood samples from patients and their parents. DNA from these samples is
isolated and then used for genetic testing. We also review medical records to compare
clinical symptoms with the detected mutations to determine if there is a correlation.
PORCN gene located on the X chromosome. This neurodevelopmental disorder is characterized by
birth defects of the skin, skeleton, eyes, and in some cases other organs. Our team is
working to obtain a better understanding of how mutations in PORCN lead to the clinical
features of Goltz syndrome. We are also trying to identify the genetic change in those
patients where no mutations in PORCN have been found. We are also investigating conditions
with phenotypes similar to Goltz syndrome to determine if they also have mutations in PORCN.
We are collecting blood samples from patients and their parents. DNA from these samples is
isolated and then used for genetic testing. We also review medical records to compare
clinical symptoms with the detected mutations to determine if there is a correlation.
Goltz syndrome or Focal Dermal Hypoplasia (FDH) is an X-linked dominant neurodevelopmental
disorder. The primary features of FDH include areas of hypoplastic skin (atrophy, linear
pigmentation and herniation of fat through dermal defects), digital patterning defects
(syndactyly, polydactyly, camptodactyly, absence deformities), ocular and dental
malformations, mild dysmorphism. Variable other defects include a pointed chin, hypoplastic
ears, nasal deformities, short stature, papillomas of lips, gingival and larynx, dystrophic
nails, sparse brittle hair. Mental retardation occurs in approximately 15%. 90% of
individuals with FDH are female. 95% percent of all cases and 100% of male cases appear de
novo.
Using array-based comparative hybridization (array-CGH) a deletion was initially identified
in PORCN in two girls with FDH. Sequencing of genes in this region has resulted in the
identification of mutations in PORCN in >75% of other individuals affected with FDH. A
manuscript describing these mutations was published in Nature Genetics (Wang, 2007). PORCN
encodes the human homolog of the Drosophila porcupine protein and has been found in
drosophila and mouse studies to be a key regulator of Wnt-protein signaling. We believe that
the PORCN mutation may cause FDH by affecting Wnt signaling, but this has yet to be proven.
For this study we are collecting information on patients with clinical findings suggestive of
FDH or with known PORCN mutations. A detailed family history will be obtained when indicated,
and additional family members will be evaluated afer appropriately obtained written voluntary
consent. A detailed report of the history or physical findings will be obtained from
referring physicians for patients identified at outside facilities or the participants may be
evaluated by the study collaborators. Blood will be obtained from affected individuals
unaffected parents and from other affected or unaffected family members where indicated.
Occasionally, affected individuals may undergo surgical procedures with removal of tissues;
in this case we may obtain tissues that would be otherwise discarded or that are not
essential for further diagnostic studies or clinical care of the patient. It is anticipated
that these specimens will be extremely valuable for understanding the pathogenesis of the
investigated conditions. DNA, RNA or protein will be prepared from leukocytes and from
tissues and used for mutation analysis and other molecular studies of the identified genes.
Permanent lymphoblastoid cell lines will be prepared and stored in the laboratory as a
permanent source of DNA for the molecular studies.
disorder. The primary features of FDH include areas of hypoplastic skin (atrophy, linear
pigmentation and herniation of fat through dermal defects), digital patterning defects
(syndactyly, polydactyly, camptodactyly, absence deformities), ocular and dental
malformations, mild dysmorphism. Variable other defects include a pointed chin, hypoplastic
ears, nasal deformities, short stature, papillomas of lips, gingival and larynx, dystrophic
nails, sparse brittle hair. Mental retardation occurs in approximately 15%. 90% of
individuals with FDH are female. 95% percent of all cases and 100% of male cases appear de
novo.
Using array-based comparative hybridization (array-CGH) a deletion was initially identified
in PORCN in two girls with FDH. Sequencing of genes in this region has resulted in the
identification of mutations in PORCN in >75% of other individuals affected with FDH. A
manuscript describing these mutations was published in Nature Genetics (Wang, 2007). PORCN
encodes the human homolog of the Drosophila porcupine protein and has been found in
drosophila and mouse studies to be a key regulator of Wnt-protein signaling. We believe that
the PORCN mutation may cause FDH by affecting Wnt signaling, but this has yet to be proven.
For this study we are collecting information on patients with clinical findings suggestive of
FDH or with known PORCN mutations. A detailed family history will be obtained when indicated,
and additional family members will be evaluated afer appropriately obtained written voluntary
consent. A detailed report of the history or physical findings will be obtained from
referring physicians for patients identified at outside facilities or the participants may be
evaluated by the study collaborators. Blood will be obtained from affected individuals
unaffected parents and from other affected or unaffected family members where indicated.
Occasionally, affected individuals may undergo surgical procedures with removal of tissues;
in this case we may obtain tissues that would be otherwise discarded or that are not
essential for further diagnostic studies or clinical care of the patient. It is anticipated
that these specimens will be extremely valuable for understanding the pathogenesis of the
investigated conditions. DNA, RNA or protein will be prepared from leukocytes and from
tissues and used for mutation analysis and other molecular studies of the identified genes.
Permanent lymphoblastoid cell lines will be prepared and stored in the laboratory as a
permanent source of DNA for the molecular studies.
Inclusion Criteria:
- Features suggestive of Goltz syndrome (not all features must be present)
- Areas of hypoplastic skin
- Digital patterning defects
- Ocular and dental malformations
- Presence of a mutation in PORCN
Exclusion Criteria:
We found this trial at
1
site
1200 Moursund Street
Houston, Texas 77030
Houston, Texas 77030
(713) 798-4951
Principal Investigator: Ignatia B Van den Veyver, MD
Phone: 713-798-4914
Baylor College of Medicine Baylor College of Medicine in Houston, the only private medical school...
Click here to add this to my saved trials
